1313026-84-4

Basic information

• Product Name: 5-(9-benzyl-2-chloro-9H-purin-6-yl)-pyrazin-2-yl-amine
• Synonyms: 5-(9-benzyl-2-chloro-9H-purin-6-yl)-pyrazin-2-yl-amine
• CAS NO: 1313026-84-4
• Molecular Weight: 337.771
• Mol File: 1313026-84-4.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 5-(9-benzyl-2-chloro-9H-purin-6-yl)-pyrazin-2-yl-amine(CAS DataBase Reference)
• NIST Chemistry Reference: 5-(9-benzyl-2-chloro-9H-purin-6-yl)-pyrazin-2-yl-amine(1313026-84-4)
• EPA Substance Registry System: 5-(9-benzyl-2-chloro-9H-purin-6-yl)-pyrazin-2-yl-amine(1313026-84-4)

Safety Data

• Hazardous Substances Data: 1313026-84-4(Hazardous Substances Data)

Upstream product

• 947249-41-4 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazin-2-amine 
• 79064-26-9 9-benzyl-2,6-dichloro-9H-purine 
• 5451-40-1 2,6 dichloropurine 
• 100-39-0 benzyl bromide 

Downstream Products

• 1313026-61-7 5-[9-benzyl-2-(8-oxa-3-aza-bicyclo[3.2.1]ocy-3-yl)-9H-purin-6-yl]-pyrazin-2-yl-amine 

Relevant articles and documents

BRIDGED MORPHOLINO SUBSTITUTED PURINES

The present invention relates to purine compounds that are useful as kinase inhibitors. More particularly, the present invention relates to purine compounds, methods for their preparation, pharmaceutical compositions containing these compounds and uses of these compounds in the treatment of proliferative conditions or disorders. These compounds may be useful as medicaments for the treatment of a number of proliferative conditions or disorders including tumours and cancers as well as other disorders or conditions related to or associated with PI3K and/or mTOR kinases.